Hospira, Inc. (NYSE:HSP)
A specialty pharmaceutical and medication delivery company that is focused on products that improve the productivity, safety and efficacy of patient care.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
bradford86
(99.55)
Submitted: 1/7/2012 9:37:46 PM :
Start Price:
$30.36
HSP Score:
+6.40
233. Hospira Inc. (NYSE: HSP) is cheap after it got murdered down from the $50's. With EPS guidance of $2.95 ballpark, this is a P/E of around 11 at present. Target: $35-$40. I think that we saw some end of year tax loss selling and that's all in the past. Clear the way for higher prices. I'm voting on this with CAPS points.
http://beta.fool.com/bradford86/2012/01/07/price-market-part-32/
Recs
CWKnob2
(< 20)
Submitted: 12/2/2011 2:51:50 PM :
Start Price:
$27.50
HSP Score:
+15.79
The stock is heavily under pressure because of manufacturing problems. This sets it up for a handful of scenarios couple of scenarios
They fix their manufacturing problems and resume business as usual
Somebody with big bucks adds HSP to their portfolio of operating companies, the new owners fix their manufacturing
So at about 9x this years earnings which include a big write off, I think it's cheap.
Recs
monkey222
(32.86)
Submitted: 12/2/2011 8:22:04 AM :
Start Price:
$27.99
HSP Score:
+14.49
Acqusition target
Recs
kbynot1
(< 20)
Submitted: 10/10/2011 10:33:29 PM :
Start Price:
$38.51
HSP Score:
-25.16
Leader in electronic surveillance platform for Hospital Acquired Infections (HAI)
Recs
latinoeconomist
(33.06)
Submitted: 8/1/2011 3:27:29 AM :
Start Price:
$51.43
HSP Score:
-37.26
High growth potential.
Recs
crubenst
(< 20)
Submitted: 5/27/2010 11:10:01 AM :
Start Price:
$51.17
HSP Score:
-57.05
Love their new aquisition of Javelin pharmaceuticals
Recs
dreese1
(43.05)
Submitted: 2/24/2009 11:48:12 AM :
Start Price:
$24.98
HSP Score:
-45.69
Not 100% sure of the solidity of this company. Still, it is healthcare and is likely to grow...
Recs
traderpat9
(81.39)
Submitted: 12/31/2008 1:11:23 PM :
Start Price:
$26.79
HSP Score:
-25.22
HOSPIRA-AN ABBOTT SPINOFF/GOING TO CONTINUE TO GROW DURING GOOD TIMES OR BAD
Recs
blackpower68
(42.31)
Submitted: 11/15/2008 10:28:21 AM :
Start Price:
$29.69
HSP Score:
-46.09
The economy may go up or down but clinics and hospital will need the supply room stocked.Also where is the CLOROX?
Recs
phatinvestor007
(92.20)
Submitted: 10/18/2008 11:47:28 AM :
Start Price:
$29.77
HSP Score:
-31.21
Cheaper drugs are needed
Recs
Recs
zdocisin
(< 20)
Submitted: 4/22/2008 5:31:19 PM :
Start Price:
$40.90
HSP Score:
+18.71
Will get caught up in its own hype, and get swallowed up by not feeding its infrastructure
Recs
qasamm
(63.50)
Submitted: 2/13/2008 6:21:21 PM :
Start Price:
$41.61
HSP Score:
-21.23
With the recall of Baxter's Heprin and a scramble for hospitals to find a replacement HSP has the oportunity to fill the void and grab a big chunk of the market.
Sales should increase with this new demand.
Recs
ashishdwivedi
(68.66)
Submitted: 11/26/2007 11:36:41 PM :
Start Price:
$42.08
HSP Score:
-19.19
Posted positive Earnings surprise recently. Good earning history.
Recs
DrStan
(46.87)
Submitted: 3/13/2007 4:10:08 PM :
Start Price:
$39.28
HSP Score:
+17.16
I owned this stock when it split from Abbott and sold it at a profit. There are too many good competitors lined up against it.
Recs
heinfr
(31.60)
Submitted: 10/11/2006 12:14:57 PM :
Start Price:
$37.27
HSP Score:
+15.41
hopsital care commodities is a tough business right now.
Recs
gailwood
(95.63)
Submitted: 8/24/2006 3:22:30 AM :
Start Price:
$35.85
HSP Score:
+16.02
Overvalued.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 18 of 18